BioTech
Teladoc became a household name under Jason Gorevic. Investors wanted more
At the J.P. Morgan Healthcare Conference in January, Teladoc CEO Jason Gorevic dismissed the growing chorus of naysayers, expressing confidence in his company’s trajectory and